The global Atherectomy Devices Market has been on a remarkable growth trajectory and is set to reach new heights during forecast period. In 2024, the market size stood at a substantial US$ 999 million.
2. Rising Incidences of Peripheral Arterial Diseases and Coronary Artery Diseases: Peripheral Arterial Diseases (PAD) and Coronary Artery Diseases (CAD) affect millions of individuals globally each year, with lifestyle factors such as smoking, diabetes, and hypertension contributing to their increasing occurrence. Atherectomy devices play a crucial role in the treatment and management of these conditions, offering reduced complications and improved surgical comfort compared to conventional treatments.
3. Surge in Adoption of Laser Atherectomy Devices: The rapid adoption of Laser Atherectomy Devices is poised to be a key driver of market expansion. These devices offer multiple advantages, including adaptability, enhanced efficiency, and the elimination of the need for embolic protection devices. Additionally, laser-embedded atherectomy devices can remove thrombi, dissolve procoagulant reactants, and debulk plaque without damaging surrounding tissues, making them a preferred choice for medical professionals.
4. Emphasis on Technological Advancements: Ongoing technological advancements in the field of atherectomy devices are expected to bolster market growth. The increasing focus on medical infrastructure expansion and extensive research efforts further contribute to the positive outlook for the market in the coming years.
2. Boston Scientific Corporation
3. Cardiovascular Systems, Inc.
4. Avinger, Inc.
5. Koninklijke Philips N.V. (Spectranetics + Volcano)
The Atherectomy Devices Market is poised for robust growth in the coming years, driven by increasing patient demand, technological advancements, and strategic industry initiatives. As the industry continues to evolve, it presents substantial opportunities for innovation and expansion.
This product will be delivered within 1-3 business days.
The Atherectomy Devices Market's remarkable growth can be attributed to several key factors:
1. Increasing Patient Pool with Atherosclerosis, Diabetes, and Obesity: The growing prevalence of chronic conditions such as Atherosclerosis, Diabetes, and Obesity has significantly expanded the patient pool for atherectomy devices. These devices are instrumental in the treatment of various orthopedic disorders, including chronic osteomyelitis, bone tumors, and osteomyelitis. Moreover, the rise in sports injuries, trauma cases, bone lesions, and fractures is expected to further drive market growth.2. Rising Incidences of Peripheral Arterial Diseases and Coronary Artery Diseases: Peripheral Arterial Diseases (PAD) and Coronary Artery Diseases (CAD) affect millions of individuals globally each year, with lifestyle factors such as smoking, diabetes, and hypertension contributing to their increasing occurrence. Atherectomy devices play a crucial role in the treatment and management of these conditions, offering reduced complications and improved surgical comfort compared to conventional treatments.
3. Surge in Adoption of Laser Atherectomy Devices: The rapid adoption of Laser Atherectomy Devices is poised to be a key driver of market expansion. These devices offer multiple advantages, including adaptability, enhanced efficiency, and the elimination of the need for embolic protection devices. Additionally, laser-embedded atherectomy devices can remove thrombi, dissolve procoagulant reactants, and debulk plaque without damaging surrounding tissues, making them a preferred choice for medical professionals.
4. Emphasis on Technological Advancements: Ongoing technological advancements in the field of atherectomy devices are expected to bolster market growth. The increasing focus on medical infrastructure expansion and extensive research efforts further contribute to the positive outlook for the market in the coming years.
Despite the optimistic growth prospects, the Atherectomy Devices Market does face certain challenges:
Challenges and Restraints:
- Lack of Awareness: In developing countries, there is limited awareness regarding the availability of disease diagnostics and therapies, which could impede market expansion. Additionally, a shortage of skilled surgeons is expected to limit growth, although government initiatives and investments are likely to promote market development.
- Pandemic Impact: The unexpected outbreak of SARS-CoV-2 led to global lockdowns and supply chain disruptions, affecting industrial growth and commerce. However, the industry has shown resilience and adaptability during these challenging times.
Competitive Landscape Analysis:
The Atherectomy Devices industry is characterized by moderate competition and high consolidation, with several prominent players.Key Companies profiled:
1. Medtronic Plc.2. Boston Scientific Corporation
3. Cardiovascular Systems, Inc.
4. Avinger, Inc.
5. Koninklijke Philips N.V. (Spectranetics + Volcano)
The Atherectomy Devices Market is poised for robust growth in the coming years, driven by increasing patient demand, technological advancements, and strategic industry initiatives. As the industry continues to evolve, it presents substantial opportunities for innovation and expansion.
Atherectomy Devices Market Categorization
Atherectomy Devices Market by Indication
- Coronary Artery Diseases
- Peripheral Artery Diseases
Atherectomy Devices Market by Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa (MEA)
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Global Atherectomy Devices Market Outlook, 2018 - 2031
4. North America Atherectomy Devices Market Outlook, 2018 - 2031
5. Europe Atherectomy Devices Market Outlook, 2018 - 2031
6. Asia Pacific Atherectomy Devices Market Outlook, 2018 - 2031
7. Latin America Atherectomy Devices Market Outlook, 2018 - 2031
8. Middle East & Africa Atherectomy Devices Market Outlook, 2018 - 2031
9. Competitive Landscape
10. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic Plc.
- Boston Scientific Corporation
- Cardiovascular Systems, Inc.
- Avinger, Inc.
- Koninklijke Philips N.V. (Spectranetics + Volcano)
Methodology
LOADING...